Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mazumdar

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
The Bone & Joint Journal|February 5, 2014
Sleep apnoea adversely affects the outcome in patients who undergo posterior lumbar fusion: a population-based studyO Stundner, Y-L Chiu, X Sun, et al.
Cancer|March 26, 1999
Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinomaP M Dodd, J A McCaffrey, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumorsR J Motzer, J Sheinfeld, M Mazumdar, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 3, 2004
The functional assessment of cancer therapy-BRM (FACT-BRM): a new tool for the assessment of quality of life in patients treated with biologic response modifiersJ Bacik, M Mazumdar, B A Murphy, et al.
Blood|July 15, 1995
Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutationsE Göker, M Waltham, A Kheradpour, et al.
Cancer Investigation|October 19, 2000
Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancerP M Dodd, J A McCaffrey, M Mazumdar, et al.
World Journal of Surgery|July 21, 2006
Prospective, blinded comparison of helical CT and CT arterial portography in the assessment of hepatic metastasis from colorectal carcinomaL Schwartz, L Brody, K Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Bicalutamide for advanced prostate cancer: the natural versus treated history of diseaseH I Scher, C Liebertz, W K Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatinH Xiao, M Mazumdar, D F Bajorin, et al.
Investigational New Drugs|January 1, 1997
A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinomaW J Berg, L H Schwartz, A Amsterdam, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
The Bone & Joint Journal|February 5, 2014
Sleep apnoea adversely affects the outcome in patients who undergo posterior lumbar fusion: a population-based studyO Stundner, Y-L Chiu, X Sun, et al.
Cancer|March 26, 1999
Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinomaP M Dodd, J A McCaffrey, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumorsR J Motzer, J Sheinfeld, M Mazumdar, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 3, 2004
The functional assessment of cancer therapy-BRM (FACT-BRM): a new tool for the assessment of quality of life in patients treated with biologic response modifiersJ Bacik, M Mazumdar, B A Murphy, et al.
Blood|July 15, 1995
Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutationsE Göker, M Waltham, A Kheradpour, et al.
Cancer Investigation|October 19, 2000
Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancerP M Dodd, J A McCaffrey, M Mazumdar, et al.
World Journal of Surgery|July 21, 2006
Prospective, blinded comparison of helical CT and CT arterial portography in the assessment of hepatic metastasis from colorectal carcinomaL Schwartz, L Brody, K Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Bicalutamide for advanced prostate cancer: the natural versus treated history of diseaseH I Scher, C Liebertz, W K Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatinH Xiao, M Mazumdar, D F Bajorin, et al.
Investigational New Drugs|January 1, 1997
A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinomaW J Berg, L H Schwartz, A Amsterdam, et al.
Pageof 11